The aim of this commentary is to discuss the published Cochrane Review “TNF-α blockers for the treatment of Kawasaki disease in children1” by Yamaji et al.,a under the direct supervision of Cochrane Review Group. This Cochrane Corner is produced in agreement with the International Journal of Rheumatic Diseases by Cochrane Rehabilitation
Are TNF‐α blockers effective and safe for Kawasaki disease in children? A Cochrane Review summary with commentary.
Antimo Moretti
2020
Abstract
The aim of this commentary is to discuss the published Cochrane Review “TNF-α blockers for the treatment of Kawasaki disease in children1” by Yamaji et al.,a under the direct supervision of Cochrane Review Group. This Cochrane Corner is produced in agreement with the International Journal of Rheumatic Diseases by Cochrane RehabilitationFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
